Cipla Ltd
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filing Details / Description
Please find enclosed press release titled ''Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda (Pembrolizumab) in the US''